BerganKDV Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $12.9K | Hold |
1,000
| – | – | ﹤0.01% | 531 |
|
2023
Q1 | $13.2K | Hold |
1,000
| – | – | ﹤0.01% | 564 |
|
2022
Q4 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 524 |
|
2022
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 554 |
|
2022
Q2 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 579 |
|
2022
Q1 | $30K | Hold |
1,000
| – | – | ﹤0.01% | 464 |
|
2021
Q4 | $27K | Buy |
1,000
+350
| +54% | +$9.45K | ﹤0.01% | 505 |
|
2021
Q3 | $24K | Hold |
650
| – | – | ﹤0.01% | 503 |
|
2021
Q2 | $28K | Hold |
650
| – | – | ﹤0.01% | 472 |
|
2021
Q1 | $22K | Hold |
650
| – | – | ﹤0.01% | 472 |
|
2020
Q4 | $23K | Hold |
650
| – | – | ﹤0.01% | 452 |
|
2020
Q3 | $16K | Hold |
650
| – | – | ﹤0.01% | 453 |
|
2020
Q2 | $12K | Buy |
650
+400
| +160% | +$7.39K | ﹤0.01% | 520 |
|
2020
Q1 | $4K | Hold |
250
| – | – | ﹤0.01% | 628 |
|
2019
Q4 | $5K | Hold |
250
| – | – | ﹤0.01% | 627 |
|
2019
Q3 | $5K | Hold |
250
| – | – | ﹤0.01% | 564 |
|
2019
Q2 | $7K | Hold |
250
| – | – | ﹤0.01% | 556 |
|
2019
Q1 | $6K | Hold |
250
| – | – | ﹤0.01% | 578 |
|
2018
Q4 | $6K | Hold |
250
| – | – | ﹤0.01% | 533 |
|
2018
Q3 | $8K | Hold |
250
| – | – | ﹤0.01% | 516 |
|
2018
Q2 | $7K | Buy |
+250
| New | +$7K | ﹤0.01% | 541 |
|